CORTENDO AB (PUBL)
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 95 Total Citation Count
- Jun 19, 1998 Earliest Filing
- 5 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9918984 Methods and compositions for treating diabetes, metabolic syndrome and other conditionsApr 01, 16Mar 20, 18[A61K]
7060679 Conformationally constrained backbone cyclized somatostatin analogsAug 12, 04Jun 13, 06[A61K]
6355613 Conformationally constrained backbone cyclized somatostatin analogsDec 02, 98Mar 12, 02[A61K, C07K]
6051554 Conformationally constrained backbone cyclized somatostatin analogsJun 19, 98Apr 18, 00[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0244,436 NOVEL FUNCTIONALIZED 5-(PHENOXYMETHYL)-1,3-DIOXANE ANALOGS EXHIBITING CYTOCHROME P450 INHIBITION AND THEIR METHOD OF USEAbandonedSep 25, 14Aug 25, 16[C07D]
2015/0353,530 NOVEL FUNCTIONALIZED 4-(PHENOXYMETHYL(-1,3-DIOXOLANE ANALOGS EXHIBITING CYTOCHROME P450 INHIBITION AND THEIR METHOD OF USEAbandonedJan 31, 14Dec 10, 15[C07D]
2015/0337,003 ABIRATERONE AND ANALOGS THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CORTISOL OVERPRODUCTIONAbandonedJan 18, 14Nov 26, 15[C07J]
2015/0210,641 NOVEL CYTOCHROME P450 INHIBITORS AND THEIR METHOD OF USEAbandonedJan 13, 15Jul 30, 15[C07D]
6930088 Conformationally constrained backbone cyclized somatostatin analogsExpiredDec 13, 00Aug 16, 05[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.